Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 1
1994 2
1995 2
1996 1
1997 3
1998 1
1999 4
2000 1
2002 3
2003 3
2004 2
2005 3
2006 3
2007 5
2008 7
2009 4
2010 5
2011 11
2012 9
2013 14
2014 13
2015 11
2016 15
2017 16
2018 16
2019 15
2020 16
2021 14
2022 9
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

202 results

Results by year

Filters applied: . Clear all
Page 1
NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis.
Glasner A, Levi A, Enk J, Isaacson B, Viukov S, Orlanski S, Scope A, Neuman T, Enk CD, Hanna JH, Sexl V, Jonjic S, Seliger B, Zitvogel L, Mandelboim O. Glasner A, et al. Among authors: sexl v. Immunity. 2018 Jan 16;48(1):107-119.e4. doi: 10.1016/j.immuni.2017.12.007. Epub 2018 Jan 9. Immunity. 2018. PMID: 29329948 Free article.
CDK8-Novel Therapeutic Opportunities.
Menzl I, Witalisz-Siepracka A, Sexl V. Menzl I, et al. Among authors: sexl v. Pharmaceuticals (Basel). 2019 Jun 19;12(2):92. doi: 10.3390/ph12020092. Pharmaceuticals (Basel). 2019. PMID: 31248103 Free PMC article. Review.
The role of CDK6 in cancer.
Nebenfuehr S, Kollmann K, Sexl V. Nebenfuehr S, et al. Among authors: sexl v. Int J Cancer. 2020 Dec 1;147(11):2988-2995. doi: 10.1002/ijc.33054. Epub 2020 May 30. Int J Cancer. 2020. PMID: 32406095 Free PMC article. Review.
Cyclin-dependent kinase inhibitors in malignant hematopoiesis.
Schirripa A, Sexl V, Kollmann K. Schirripa A, et al. Among authors: sexl v. Front Oncol. 2022 Aug 11;12:916682. doi: 10.3389/fonc.2022.916682. eCollection 2022. Front Oncol. 2022. PMID: 36033505 Free PMC article. Review.
Stress signaling boosts interferon-induced gene transcription in macrophages.
Boccuni L, Podgorschek E, Schmiedeberg M, Platanitis E, Traxler P, Fischer P, Schirripa A, Novoszel P, Nebreda AR, Arthur JSC, Fortelny N, Farlik M, Sexl V, Bock C, Sibilia M, Kovarik P, Müller M, Decker T. Boccuni L, et al. Among authors: sexl v. Sci Signal. 2022 Dec 13;15(764):eabq5389. doi: 10.1126/scisignal.abq5389. Epub 2022 Dec 13. Sci Signal. 2022. PMID: 36512641
Vaccination-based immunotherapy to target profibrotic cells in liver and lung.
Sobecki M, Chen J, Krzywinska E, Nagarajan S, Fan Z, Nelius E, Monné Rodriguez JM, Seehusen F, Hussein A, Moschini G, Hajam EY, Kiran R, Gotthardt D, Debbache J, Badoual C, Sato T, Isagawa T, Takeda N, Tanchot C, Tartour E, Weber A, Werner S, Loffing J, Sommer L, Sexl V, Münz C, Feghali-Bostwick C, Pachera E, Distler O, Snedeker J, Jamora C, Stockmann C. Sobecki M, et al. Among authors: sexl v. Cell Stem Cell. 2022 Oct 6;29(10):1459-1474.e9. doi: 10.1016/j.stem.2022.08.012. Epub 2022 Sep 15. Cell Stem Cell. 2022. PMID: 36113462 Free article.
CDK4/6 and MAPK-Crosstalk as Opportunity for Cancer Treatment.
Scheiblecker L, Kollmann K, Sexl V. Scheiblecker L, et al. Among authors: sexl v. Pharmaceuticals (Basel). 2020 Nov 24;13(12):418. doi: 10.3390/ph13120418. Pharmaceuticals (Basel). 2020. PMID: 33255177 Free PMC article. Review.
CDK6 Inhibition: A Novel Approach in AML Management.
Uras IZ, Sexl V, Kollmann K. Uras IZ, et al. Among authors: sexl v. Int J Mol Sci. 2020 Apr 5;21(7):2528. doi: 10.3390/ijms21072528. Int J Mol Sci. 2020. PMID: 32260549 Free PMC article. Review.
202 results